AAPL276.63-16.54 (-5.64%) ▼|ABBV242.91+8.02 (+3.41%) ▲|ABT94.17+3.68 (+4.06%) ▲|ACN127.43-1.72 (-1.33%) ▼|ADBE193.90-2.65 (-1.35%) ▼|AMAT628.01+39.05 (+6.63%) ▲|AMD514.92-4.14 (-0.80%) ▼|AMGN356.56+5.17 (+1.47%) ▲|AMT167.69-6.77 (-3.88%) ▼|AMZN228.75-5.62 (-2.40%) ▼|AVGO378.07-4.01 (-1.05%) ▼|AXP346.65+4.09 (+1.19%) ▲|BA220.66+0.41 (+0.19%) ▲|BAC58.72+0.99 (+1.71%) ▲|BKNG179.33-1.95 (-1.07%) ▼|BLK976.33-6.27 (-0.64%) ▼|BMY56.00+1.00 (+1.81%) ▲|BNY146.48+2.92 (+2.03%) ▲|BRK-B493.04-1.77 (-0.36%) ▼|C146.20+2.61 (+1.82%) ▲|CAT1,040.30+45.85 (+4.61%) ▲|CL91.70-0.19 (-0.20%) ▼|CMCSA22.84+0.20 (+0.86%) ▲|COF206.48+6.00 (+2.99%) ▲|COP106.74-0.18 (-0.17%) ▼|COST944.64-16.33 (-1.70%) ▼|CRM149.52-3.24 (-2.12%) ▼|CSCO118.67-1.07 (-0.89%) ▼|CVS104.20+2.33 (+2.29%) ▲|CVX172.08+0.63 (+0.37%) ▲|DE617.44+16.69 (+2.78%) ▲|DHR194.57+5.70 (+3.02%) ▲|DIS100.54-0.58 (-0.57%) ▼|DUK127.64+1.11 (+0.88%) ▲|EMR144.80+3.36 (+2.37%) ▲|FDX326.19+9.36 (+2.95%) ▲|GD345.65+1.33 (+0.39%) ▲|GE375.23+9.35 (+2.56%) ▲|GEV1,088.46+30.81 (+2.91%) ▲|GILD125.51+0.36 (+0.29%) ▲|GM80.06+1.11 (+1.41%) ▲|GOOG339.62-5.41 (-1.57%) ▼|GOOGL340.03-5.26 (-1.52%) ▼|GS1,084.87+7.96 (+0.74%) ▲|HD345.75+2.89 (+0.84%) ▲|HON232.79+5.37 (+2.36%) ▲|IBM258.70-4.27 (-1.62%) ▼|INTC128.34-3.57 (-2.71%) ▼|INTU256.04-6.30 (-2.40%) ▼|ISRG405.74+3.91 (+0.97%) ▲|JNJ246.86+5.86 (+2.43%) ▲|JPM339.58+6.13 (+1.84%) ▲|KO80.65+0.05 (+0.06%) ▲|LIN526.81+11.08 (+2.15%) ▲|LLY1,140.50+23.24 (+2.08%) ▲|LMT507.20+15.56 (+3.16%) ▲|LOW222.86+1.41 (+0.63%) ▲|LRCX378.81+3.99 (+1.06%) ▲|MA497.97+3.56 (+0.72%) ▲|MCD269.37-4.51 (-1.65%) ▼|MDLZ62.34+0.60 (+0.97%) ▲|MDT82.04+1.91 (+2.38%) ▲|META550.15-7.65 (-1.37%) ▼|MMM167.69+1.78 (+1.07%) ▲|MO73.19+1.12 (+1.55%) ▲|MRK124.13+3.53 (+2.93%) ▲|MS223.55+3.69 (+1.68%) ▲|MSFT354.41-11.04 (-3.02%) ▼|MU1,169.14+121.22 (+11.57%) ▲|NEE87.78+0.16 (+0.18%) ▲|NFLX71.86+0.02 (+0.02%) ▲|NKE40.90-0.93 (-2.21%) ▼|NOW89.69-4.12 (-4.39%) ▼|NVDA195.00-3.91 (-1.97%) ▼|ORCL150.67-6.87 (-4.36%) ▼|PEP140.92-1.36 (-0.95%) ▼|PFE24.05+0.01 (+0.02%) ▲|PG150.15-1.89 (-1.24%) ▼|PLTR106.83-6.69 (-5.89%) ▼|PM179.89+2.58 (+1.46%) ▲|QCOM202.15+4.83 (+2.45%) ▲|RTX187.46+2.40 (+1.30%) ▲|SBUX103.22-0.30 (-0.29%) ▼|SCHW91.18-0.21 (-0.23%) ▼|SO96.18+0.40 (+0.42%) ▲|SPG224.40+2.25 (+1.01%) ▲|T22.52+0.15 (+0.68%) ▲|TMO506.98+14.78 (+3.00%) ▲|TMUS181.49+0.70 (+0.38%) ▲|TSLA372.74-2.73 (-0.73%) ▼|TXN309.03+5.92 (+1.95%) ▲|UBER72.51-1.34 (-1.81%) ▼|UNH414.12+8.32 (+2.05%) ▲|UNP265.61+5.65 (+2.17%) ▲|UPS108.70+2.56 (+2.41%) ▲|USB61.31+1.20 (+1.99%) ▲|V336.49+4.26 (+1.28%) ▲|VZ45.98+0.30 (+0.65%) ▲|WFC85.55+1.25 (+1.48%) ▲|WMT117.11-1.90 (-1.60%) ▼|XOM137.37+0.47 (+0.34%) ▲|AAPL276.63-16.54 (-5.64%) ▼|ABBV242.91+8.02 (+3.41%) ▲|ABT94.17+3.68 (+4.06%) ▲|ACN127.43-1.72 (-1.33%) ▼|ADBE193.90-2.65 (-1.35%) ▼|AMAT628.01+39.05 (+6.63%) ▲|AMD514.92-4.14 (-0.80%) ▼|AMGN356.56+5.17 (+1.47%) ▲|AMT167.69-6.77 (-3.88%) ▼|AMZN228.75-5.62 (-2.40%) ▼|AVGO378.07-4.01 (-1.05%) ▼|AXP346.65+4.09 (+1.19%) ▲|BA220.66+0.41 (+0.19%) ▲|BAC58.72+0.99 (+1.71%) ▲|BKNG179.33-1.95 (-1.07%) ▼|BLK976.33-6.27 (-0.64%) ▼|BMY56.00+1.00 (+1.81%) ▲|BNY146.48+2.92 (+2.03%) ▲|BRK-B493.04-1.77 (-0.36%) ▼|C146.20+2.61 (+1.82%) ▲|CAT1,040.30+45.85 (+4.61%) ▲|CL91.70-0.19 (-0.20%) ▼|CMCSA22.84+0.20 (+0.86%) ▲|COF206.48+6.00 (+2.99%) ▲|COP106.74-0.18 (-0.17%) ▼|COST944.64-16.33 (-1.70%) ▼|CRM149.52-3.24 (-2.12%) ▼|CSCO118.67-1.07 (-0.89%) ▼|CVS104.20+2.33 (+2.29%) ▲|CVX172.08+0.63 (+0.37%) ▲|DE617.44+16.69 (+2.78%) ▲|DHR194.57+5.70 (+3.02%) ▲|DIS100.54-0.58 (-0.57%) ▼|DUK127.64+1.11 (+0.88%) ▲|EMR144.80+3.36 (+2.37%) ▲|FDX326.19+9.36 (+2.95%) ▲|GD345.65+1.33 (+0.39%) ▲|GE375.23+9.35 (+2.56%) ▲|GEV1,088.46+30.81 (+2.91%) ▲|GILD125.51+0.36 (+0.29%) ▲|GM80.06+1.11 (+1.41%) ▲|GOOG339.62-5.41 (-1.57%) ▼|GOOGL340.03-5.26 (-1.52%) ▼|GS1,084.87+7.96 (+0.74%) ▲|HD345.75+2.89 (+0.84%) ▲|HON232.79+5.37 (+2.36%) ▲|IBM258.70-4.27 (-1.62%) ▼|INTC128.34-3.57 (-2.71%) ▼|INTU256.04-6.30 (-2.40%) ▼|ISRG405.74+3.91 (+0.97%) ▲|JNJ246.86+5.86 (+2.43%) ▲|JPM339.58+6.13 (+1.84%) ▲|KO80.65+0.05 (+0.06%) ▲|LIN526.81+11.08 (+2.15%) ▲|LLY1,140.50+23.24 (+2.08%) ▲|LMT507.20+15.56 (+3.16%) ▲|LOW222.86+1.41 (+0.63%) ▲|LRCX378.81+3.99 (+1.06%) ▲|MA497.97+3.56 (+0.72%) ▲|MCD269.37-4.51 (-1.65%) ▼|MDLZ62.34+0.60 (+0.97%) ▲|MDT82.04+1.91 (+2.38%) ▲|META550.15-7.65 (-1.37%) ▼|MMM167.69+1.78 (+1.07%) ▲|MO73.19+1.12 (+1.55%) ▲|MRK124.13+3.53 (+2.93%) ▲|MS223.55+3.69 (+1.68%) ▲|MSFT354.41-11.04 (-3.02%) ▼|MU1,169.14+121.22 (+11.57%) ▲|NEE87.78+0.16 (+0.18%) ▲|NFLX71.86+0.02 (+0.02%) ▲|NKE40.90-0.93 (-2.21%) ▼|NOW89.69-4.12 (-4.39%) ▼|NVDA195.00-3.91 (-1.97%) ▼|ORCL150.67-6.87 (-4.36%) ▼|PEP140.92-1.36 (-0.95%) ▼|PFE24.05+0.01 (+0.02%) ▲|PG150.15-1.89 (-1.24%) ▼|PLTR106.83-6.69 (-5.89%) ▼|PM179.89+2.58 (+1.46%) ▲|QCOM202.15+4.83 (+2.45%) ▲|RTX187.46+2.40 (+1.30%) ▲|SBUX103.22-0.30 (-0.29%) ▼|SCHW91.18-0.21 (-0.23%) ▼|SO96.18+0.40 (+0.42%) ▲|SPG224.40+2.25 (+1.01%) ▲|T22.52+0.15 (+0.68%) ▲|TMO506.98+14.78 (+3.00%) ▲|TMUS181.49+0.70 (+0.38%) ▲|TSLA372.74-2.73 (-0.73%) ▼|TXN309.03+5.92 (+1.95%) ▲|UBER72.51-1.34 (-1.81%) ▼|UNH414.12+8.32 (+2.05%) ▲|UNP265.61+5.65 (+2.17%) ▲|UPS108.70+2.56 (+2.41%) ▲|USB61.31+1.20 (+1.99%) ▲|V336.49+4.26 (+1.28%) ▲|VZ45.98+0.30 (+0.65%) ▲|WFC85.55+1.25 (+1.48%) ▲|WMT117.11-1.90 (-1.60%) ▼|XOM137.37+0.47 (+0.34%) ▲|
26.5 C
New York
Thursday, June 25, 2026

Tag: stage

newssourceFORcompanyinformationcontent1marketreleases

【COMPUTEX 2026】Compal Integrates Quantum Technology and AI – Partnering with Top Universities and Pharmaceutical Firms to Build a Biotech AI Platform

TAIPEI, June 4, 2026 /PRNewswire/ -- Compal Electronics (Compal; TWSE: 2324) showcases its landmark achievements in Quantum Technology and Advanced Artificial Intelligence (AI) at COMPUTEX...

“Go AI Native with MuleRun” Lights Up New York Tech Week

NEW YORK, June 4, 2026 /CNW/ -- As part of New York Tech Week, MuleRun successfully hosted "Go AI Native with MuleRun – Key...

AIRM Sets a New Standard for Brand Reputation Management in AI Search

SINGAPORE, June 04, 2026 (GLOBE NEWSWIRE) -- Rankpage has launched AIRM, an AI Reputation Management system developed to help businesses monitor, analyse, manage, and improve how their brands appear across AI-generated answers.

match.asia Launches Exit HealthCheck to Help SMEs Avoid Common M&A Deal Killers

Free exit readiness service helps business owners identify problem areas before entering the M&A market. 
Free exit readiness service helps business owners identify problem areas before entering the M&A market.

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).

Gujarat becomes the New Hub in Organ Transplantation

Zydus Hospitals Ahmedabad and Vadodara reach new heights in advanced transplant care AHMEDABAD, India, June 4, 2026 /PRNewswire/ -- Organ transplantation in India has come a...

The OREO Brand & BTS Movement is On! Introducing the Limited Edition OREO & BTS Cookies

BTS is sharing a taste of their Korean roots through a new OREO cookie they created.Official Video: HEREThe OREO cookie offers a taste of...

FGR accelerates USA expansion & defence sector exposure with strategic acquisition of MITO® Material Solutions

HighlightsFGR enters binding agreement to acquire all assets, intellectual property, product lines and manufacturing capabilities of USA-based MITO® Material Solutions, Inc.Strategic acquisition expands FGR's...

Bell Announces Upsizing and Results of its Cash Tender Offers for Debt Securities

This news release contains forward-looking statements. For a description of the related risk factors and assumptions, please see the section entitled "Caution Concerning Forward-Looking...

Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032

MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the “Convertible Notes”). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000.

FGR accelerates USA expansion & defence sector exposure with strategic acquisition of MITO® Material Solutions

HighlightsFGR enters binding agreement to acquire all assets, intellectual property, product lines and manufacturing capabilities of USA-based MITO® Material Solutions, Inc.Strategic acquisition expands FGR's...

FGR accelerates USA expansion & defence sector exposure with strategic acquisition of MITO® Material Solutions

HighlightsFGR enters binding agreement to acquire all assets, intellectual property, product lines and manufacturing capabilities of USA-based MITO® Material Solutions, Inc.Strategic acquisition expands FGR's...

Bell Announces Results of its Cash Tender Offers for Six Series of Debt Securities

This news release contains forward-looking statements. For a description of the related risk factors and assumptions, please see the section entitled "Caution Concerning Forward-Looking...

POP Biotechnologies Secures Up to $9.7 Million in CEPI Funding

Funding to Propel POP BIO SNAP™ Nanoparticle Vaccine Platform into Phase 1 Clinical Trials in the U.S. 
Funding to Propel POP BIO SNAP™ Nanoparticle Vaccine Platform into Phase 1 Clinical Trials in the U.S.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsStage

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers